Aortic Aneurysm Repair Devices Market Report 2025 (Global Edition)

Global Aortic Aneurysm Repair Devices Market Report 2025 Market Size Split by Type (stent grafts, catheters, guide wires, others), by Application (Abdominal Aortic Aneurysm Repair, Thoracic Aortic Ane...

Aortic Aneurysm Repair Devices Market Report Description

We have various report editions of Aortic Aneurysm Repair Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Competitive Landscape

The aortic aneurysm repair devices market is moderately consolidated, with key players focusing on device miniaturization, advanced graft design, and expansion into complex anatomies. Strategic partnerships, clinical trials, and regulatory approvals drive competitiveness.

Recent Developments

• In 2023, Medtronic received FDA approval for its Endurant II stent graft system for complex AAA anatomy. 
• Cook Medical launched the Zilver Vena stent in Japan, targeting venous and aortic applications with enhanced radial strength.
• Gore Medical initiated a multicentre trial for its TAMBE branched endoprosthesis for complex thoracoabdominal repairs. 
   

Top Companies Market Share in Aortic Aneurysm Repair Devices Industry: (In no particular order of Rank)

• Medtronic plc
• Cook Medical
• W. L. Gore & Associates
• Inc.
• Terumo Corporation
• Endologix LLC
• Lombard Medical
• MicroPort Scientific Corporation
• CryoLife
• Inc.
• Cardinal Health
• Inc.
• Boston Scientific Corporation
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Which Region Dominates the Market?

North America leads the global market, driven by high awareness, advanced healthcare infrastructure, and favourable reimbursement policies. The U.S. performs the largest number of EVAR procedures globally, supported by guidelines from the Society for Vascular Surgery (SVS) and American College of Cardiology (ACC). Medicare coverage, strong diagnostic screening uptake, and the presence of major device manufacturers contribute to high regional penetration.
Additionally, clinical research and trials for next-generation devices are concentrated in the U.S. and Canada, with early adoption of branched and fenestrated stent grafts for complex aortic anatomies. Hybrid operating rooms, advanced imaging equipment, and well-trained vascular specialists further reinforce North America’s leadership in minimally invasive aneurysm repair.

Which is the Fastest Growing Region in the Market?

Asia-Pacific is the fastest-growing region due to the increasing prevalence of cardiovascular disease, expanding access to vascular diagnostics, and rising healthcare investments. Countries like China, India, and Japan are witnessing higher diagnosis rates of aortic aneurysms due to better imaging access and clinical training.
Government healthcare reforms and insurance expansion have led to greater affordability of endovascular procedures in urban hospitals. Japan, in particular, has rapidly adopted TEVAR for thoracic cases, while India and China are investing in domestic device production and training vascular specialists. Asia-Pacific's large aging population and infrastructure growth are expected to sustain rapid expansion in aneurysm repair device usage over the coming years.
 

The current report Scope analyzes Aortic Aneurysm Repair Devices Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

Aortic Aneurysm Repair Devices Market Analysis

The aortic aneurysm repair devices market is segmented into stent grafts, catheters, guide wires, and other accessories such as sheaths and introducers. Among these, stent grafts dominate the market as the central component of both EVAR (endovascular aneurysm repair) and TEVAR (thoracic endovascular aneurysm repair) procedures. These self-expanding or balloon-expandable grafts are designed to reinforce the aortic wall and isolate the aneurysmal sac from blood flow, effectively preventing rupture. The dominance of stent grafts is further reinforced by continuous innovations such as low-profile delivery systems, fenestrated grafts for complex anatomies, and hybrid materials that improve flexibility and sealing. While catheters and guide wires are essential for device delivery and positioning, they serve a supportive role and do not hold the same clinical or commercial value as stent grafts.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Aortic Aneurysm Repair Devices Industry. Request a Free Sample PDF!

Application Segment Analysis of Aortic Aneurysm Repair Devices Market

This report analyzes revenue growth in the pharma and healthcare industry at global, regional, and national levels, highlighting trends and opportunities for each application. It explores how sectors like pharmaceuticals, therapy, and healthcare monitoring use innovations to address healthcare needs. Key factors include market size, revenue contributions, technological advancements (e.g., AI-driven diagnostics), and regulatory considerations. The report also covers the value chain, identifying key players and processes within the industry. For more information, please request a sample or contact our research team.

Some of the key Application of Aortic Aneurysm Repair Devices are:

• Abdominal Aortic Aneurysm Repair
• Thoracic Aortic Aneurysm Repair

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Aortic Aneurysm Repair Devices Aneurysm Type Segment Analysis

This market is classified by aneurysm type into abdominal aortic aneurysms (AAA), thoracic aortic aneurysms (TAA), and thoracoabdominal aortic aneurysms (TAAA). Among these, abdominal aortic aneurysms (AAA) represent the largest share due to their higher prevalence and routine use of screening programs. AAA is particularly common among older males, smokers, and those with hypertension or a family history of vascular disease. Because many AAAs are asymptomatic until rupture, elective repair using EVAR has become a widely adopted preventive strategy, especially in countries with national screening protocols like the UK and the U.S. In contrast, TAA and TAAA cases are more complex, often requiring branched or fenestrated stent grafts and being limited to specialized centers. As such, while clinically important, these segments contribute less to overall procedure volume.

• Abdominal aortic aneurysms (AAA)
• Thoracic aortic aneurysms (TAA)
• Thoracoabdominal aortic aneurysms (TAAA)

Aortic Aneurysm Repair Devices Procedure Type Segment Analysis

In terms of procedural approach, the market includes endovascular aneurysm repair (EVAR), thoracic endovascular aneurysm repair (TEVAR), and open surgical repair. EVAR dominates the market, primarily because of its minimally invasive nature, reduced perioperative morbidity, and shorter recovery time compared to open repair. EVAR is now the standard of care for many patients with suitable AAA anatomy, particularly those deemed high-risk for conventional surgery. TEVAR is growing steadily, especially for descending thoracic aortic lesions, but is still used less frequently overall than EVAR. Open surgical repair remains essential for complex or ruptured aneurysms that are not amenable to endovascular techniques, yet its share is declining due to the evolution of stent grafts and broader EVAR eligibility.

• Endovascular Aneurysm Repair (EVAR)
• Thoracic Endovascular Aneurysm Repair (TEVAR)
• Open Surgical Repair

Aortic Aneurysm Repair Devices End-User Segment Analysis

Based on end-use, the market is segmented into hospitals, ambulatory surgical centers (ASCs), specialty vascular clinics, and academic & research institutions. Hospitals dominate this segment, as they are best equipped with the necessary facilities, imaging infrastructure, and specialized personnel required for aneurysm repair. Most EVAR and TEVAR procedures are performed in tertiary or quaternary hospitals with dedicated vascular surgery departments or hybrid operating rooms. Emergency repairs for ruptured aneurysms, postoperative monitoring, and access to intensive care units (ICUs) also make hospitals the default setting for such interventions. While ASCs and specialty vascular clinics are emerging in developed regions, particularly for elective EVAR procedures, their scope remains narrower due to complexity and resource requirements.

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Vascular Clinics
• Academic & Research Institutions.

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion